More than 5,000 Graco infant car seats sold through Target, Walmart and other major retailers are being recalled in the United States after the company and federal regulators warned of an injury risk tied to the seat base.

The recall applies to Graco SnugRide Turn & Slide car seats sold in the United States from January 2026 through March 2026 at Amazon, Babylist, Target, Walmart and on Graco’s website.

“At Graco, the safety of children and the trust of parents and caregivers are at the heart of everything we do,” Graco said in a statement announcing the voluntary recall on Monday. 

“We know parents rely on Graco products every day, and we understand this may create frustration and disruption for families,” the statement continued. “We are working quickly to support affected families and will provide a replacement product at no cost.”

FORD RECALLS 1.74 MILLION VEHICLES DUE TO REARVIEW CAMERA BLACKOUTS, ISSUES

Graco has announced a voluntary recall of select SnugRide Turn & Slide products sold at major retailers including Amazon, Target, and Walmart between January 2026 and March 2026. The company stated the recall was initiated after a structural issu (Graco)

This recall was “due to a structural issue identified during a post-production laboratory test,” according to Graco.

According to a Department of Transportation recall report, 5,126 units are potentially involved. The report warns of “increased risk of injury.”

“A properly seated carrier may detach from the convenience base under certain crash conditions,” the DOT defect description for the Rearfacing Infant Seat reads. “The base locking hooks may allow the carrier to detach.”

CALIFORNIA TODDLER FALLS OUT OF MOVING CAR, MOTHER CHARGED

The recall impacts as many as 5,126 infant car seats. (Graco)

The recall applies only to select SnugRide Turn & Slide models, including some infant car seats, bases and Modes Nest travel systems with the matching car seat. Graco said no other rotating car seats are affected, including EasyTurn and Turn2Me, and no other SnugRide models are included.

Consumers are being told to stop using the seat with the base, though Graco said the seat can still be used without the base if installed with the vehicle seat belt and according to product instructions.

CLICK HERE TO READ MORE ON FOX BUSINESS

The company is offering free replacement products, including infant seats, toddler seats or, for base-only purchases, a replacement base.

Graco said affected owners should check the model number on the base label, upload a photo of the white label and complete the company’s recall registration form.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Customers should not return the product to stores, according to Graco.

Thom Tillis, an influential Republican senator on the committee which oversees nominations for the Federal Reserve chair, has threatened to block Warsh’s confirmation. If Warsh is not confirmed before Powell’s term expires, he plans to stay on temporarily in the post.

This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

NEW YORK — Upstart Holdings Inc. shares jumped more than 11 percent in midday trading Wednesday, climbing to around $32.96 as investors bet on the artificial intelligence-powered lending platform’s continued recovery in 2026 amid improving loan origination volumes and optimism around its push for a national bank charter.

At approximately 12:48 p.m. EDT on April 15, 2026, UPST stock had risen $3.43, or 11.62 percent, from the previous close on elevated volume. The San Mateo, California-based company’s market capitalization approached $3.2 billion after the sharp move, reflecting renewed enthusiasm for AI-driven fintech names following signs of stabilization in consumer credit markets.

The rally builds on earlier gains triggered by strong fiscal 2025 results and upbeat full-year 2026 guidance released in February. Upstart reported fourth-quarter revenue of $296 million, up 35 percent year-over-year and beating estimates, while posting positive GAAP earnings per share of $0.17. For the full year 2025, revenue climbed 64 percent to roughly $1.08 billion with net income turning positive at $53.6 million after prior losses.

Management guided for approximately $1.4 billion in 2026 revenue — well above the $1.27 billion analysts had projected at the time — while targeting a compound annual growth rate of about 35 percent through 2028 and adjusted EBITDA margins approaching 25 percent in the longer term. The optimistic outlook helped spark an 11 percent after-hours pop in February and set the stage for the current momentum.

Upstart’s core platform uses machine learning models to assess creditworthiness beyond traditional FICO scores, incorporating thousands of variables including education, job history and alternative data. This approach has enabled partner banks and credit unions to approve more borrowers at lower interest rates while maintaining strong risk performance. The company connects consumers seeking personal loans, auto loans and other credit products with over 100 lending partners.

Recent operational highlights include new partnerships, such as DuPage Credit Union’s collaboration for personal loans announced in early April, and forward-flow commitments with institutional investors to support origination growth. In March, Upstart revealed plans to apply for a national bank charter and form a bank holding company, a transformative move that could allow it to accept deposits and fund loans directly rather than relying solely on third-party capital.

CEO Dave Girouard has described the bank charter initiative as a way to de-risk the business model by creating more stable, lower-cost funding sources. If approved, the shift could reduce dependence on volatile institutional funding markets and improve margins over time. The application adds strategic upside but also introduces regulatory uncertainty typical of fintech efforts to enter traditional banking.

Wall Street remains divided yet leans constructive overall. Across 16 analysts tracked, the consensus rating is Hold with an average 12-month price target near $48, implying roughly 45 to 50 percent upside from current levels. Targets range from a low of $20 to a high of $80. Firms such as Piper Sandler and BTIG have issued Buy ratings in recent months, while others like Bank of America have trimmed targets modestly to $36 from $40 while maintaining Hold. Some models project fair value around $44 to $45 under base-case assumptions of sustained revenue growth and margin expansion.

The stock has been volatile. It entered 2026 under pressure, down roughly 44 percent at one point amid broader concerns over consumer spending and funding availability for nonprime lending. Yet early signs of recovery — including positive transaction growth and returning profitability — have encouraged bulls who see the current valuation as attractive relative to growth prospects. The shares trade at a price-to-sales multiple well below historical averages, offering what some view as a discounted entry into the AI lending space.

Next earnings for the first quarter of fiscal 2026 are scheduled for May 5 after the market close, with a conference call set for 4:30 p.m. ET. Analysts will scrutinize origination volumes, contribution margins, funding partner activity and any updates on the bank charter application or new product verticals such as earned wage access and revolving credit lines launched earlier in the year.

Challenges persist. Upstart faces ongoing litigation, including a recent class-action lawsuit alleging that its AI models were calibrated too conservatively in response to macroeconomic signals, leading to lower approval rates and missed revenue opportunities. The company has also navigated a tougher funding environment in prior quarters, though new institutional commitments and share repurchase activity signal management confidence.

Broader economic factors weigh heavily. Higher interest rates have cooled consumer borrowing demand, particularly among lower-credit borrowers who form much of Upstart’s addressable market. Any slowdown in job growth or rise in delinquencies could pressure origination volumes. Competition from traditional banks, other fintech lenders like SoFi and Affirm, and evolving regulatory scrutiny around alternative credit scoring add layers of risk.

For investors debating buy or sell decisions in 2026, Upstart represents a high-beta play on AI applications in financial services. Bulls highlight the company’s technological edge, scalable platform and path to becoming a more vertically integrated lender through the bank charter. With revenue guidance pointing to strong double-digit growth and potential margin leverage as scale returns, the stock offers asymmetric upside if execution remains solid. Recent insider buying and aggressive share repurchases in prior periods have reinforced that narrative.

Skeptics point to execution risks in scaling new funding sources, dependency on macroeconomic tailwinds for consumer credit and the possibility that AI advantages prove less durable than hoped amid regulatory pushback or model performance issues. The stock’s history of sharp swings — including massive gains in 2020-2021 followed by steep declines — underscores the volatility inherent in early-stage fintech disruptors.

At current levels near $32.96, Upstart trades with a market capitalization that some analysts view as reasonable given projected 2026 revenue near $1.4 billion. The absence of a dividend keeps the focus squarely on growth, while the upcoming earnings report on May 5 will serve as a key test of whether early recovery trends are sustainable.

Longer-term forecasts vary. Optimistic scenarios see the stock doubling by year-end if origination volumes accelerate and the bank charter progresses smoothly. More conservative models call for modest single-digit to low-double-digit gains, assuming steady but not explosive growth. The 35 percent CAGR target through 2028 provides a ambitious benchmark that would justify significant multiple expansion if achieved.

As spring progresses, attention will turn to monthly origination updates, progress on new verticals and any regulatory developments tied to the bank application. Broader market sentiment toward AI and fintech stocks will also influence price action, with positive macro data on employment and consumer spending likely to support the name.

Upstart built its reputation on using AI to expand access to credit responsibly. After navigating a challenging post-pandemic period of high rates and funding constraints, the company appears positioned for a potential inflection in 2026. Whether that translates into sustained shareholder returns depends on delivering consistent origination growth, prudent risk management and successful navigation of the regulatory path ahead.

For now, the market is rewarding signs of momentum with a double-digit move. Short-term traders may ride the wave into earnings, while longer-term investors will watch for confirmation that the AI lending model can thrive across economic cycles. The golden promise of smarter credit decisions remains intact, but execution in a still-cautious borrowing environment will determine if 2026 becomes the breakout year many bulls anticipate.